Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the ...

Some companies use just enough scientific jargon to make false claims sound believable. Or they overstate their products' benefits while understating the risks.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

I suspect I’ve been infected by one of the flu-like viruses currently surging in China, though our own Department of Health (DOH) insists there’s no cause for alarm. In other words, there’s no ...

People still see COVID-19 as an ongoing public health threat, even though the pandemic officially ended in 2023, acc ...

Follow along today for ongoing coverage of Robert F. Kennedy Jr.'s second Senate confirmation hearing.  | Coverage of Robert ...

Critics of President Donald Trump’s pick to lead the country’s health care agency have framed Kennedy as a conspiracy ...

Inesa Ponomariovaite The U.S. health sector is on the brink of a transformative era. From the Food and Drug Administration’s ...

The Federal Drug Administration is warning Americans to absolutely beware of one brand's potato chips because for those ...